<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00787683</url>
  </required_header>
  <id_info>
    <org_study_id>V7.0</org_study_id>
    <nct_id>NCT00787683</nct_id>
  </id_info>
  <brief_title>Home-Monitoring in Implantable Cardioverter Defibrillator (ICD) Patients</brief_title>
  <acronym>Monitor-ICD</acronym>
  <official_title>Home-Monitoring in ICD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>F. Mueller-Riemenschneider</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the cost-effectiveness and effectiveness of
      remote-monitoring compared to standard care in patients with implantable cardioverter
      defibrillator.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Implantable cardioverter defibrillator (ICD) are an important and effective treatment in
      patients at risk of sudden cardiac death. In order to allow for a more continuous follow-up
      and reduced complication rates of patients with ICD, new devices including remote-monitoring
      (home-monitoring) features of patients with ICD have been developed. BIOTRONIK Home
      Monitoring service enables the doctors to safely follow up their patients with implanted
      cardioverter-defibrillators in a remote fashion, with fewer in-clinic consultations. This may
      result in a more efficient follow-up and cost-savings for the health care payer.

      The objective of the current study is to investigate the cost-effectiveness and effectiveness
      of home-monitoring compared to standard care.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of disease specific costs from a societal perspective.</measure>
    <time_frame>up to 24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of shocks</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital admissions</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac events</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease specific Costs from third party payers perspective</measure>
    <time_frame>up 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall costs from societal and third party payers perspective</measure>
    <time_frame>up to 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">416</enrollment>
  <condition>Ventricular Arrythmias</condition>
  <arm_group>
    <arm_group_label>Home-monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive an additional home-monitoring (remote-monitoring) device (CardioMessengerII) following Biotronik Lumax ICD implantation. The device enables regular transmission and examination of ICD information via home-monitoring. Follow-up appointments in outpatient clinic are changed compared to standard care. While follow-up 1, 12, and 24 months after ICD implantation consist of outpatient clinic appointments, follow-up 3, 6, and 18 months after ICD implantation are conducted remotely.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients randomised to the standard care group receive no home-monitoring device (CardioMessengerII) following Lumax ICD implantation. Patients have scheduled follow-up appointments at the ICD outpatient clinics at 1, 3, 6, 12, 18, and 24 months after ICD implantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Home-monitoring provided by LUMAX ICD device and CardioMessenger II</intervention_name>
    <description>All study participants receive an ICD of the Biotronik lumax family. Only participants of the intervention group receive the CardioMessengerII to allow for transmission of regular home monitoring messages. All study participants will be followed for 12 to 24 months (depending on the time of recruitment). The intervention and comparison to be investigated is home-monitoring vs. no home-monitoring. The intervention involves a combination of in-clinic consultations and regular use of home-monitoring services. As part of the modified follow-up schedule of intervention patients compared to standard care, follow-up in-clinic consultations 3, 6, and 18 months after ICD implantation will be replaced by home-monitoring follow-up.</description>
    <arm_group_label>Home-monitoring</arm_group_label>
    <other_name>Home-monitoring</other_name>
    <other_name>Remote-monitoring</other_name>
    <other_name>Tele-monitoring</other_name>
    <other_name>ICD</other_name>
    <other_name>Biotronik</other_name>
    <other_name>Lumax</other_name>
    <other_name>CardioMessenger</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient is willing/able to undergo the study protocol appointments and
             procedures/questionnaires

          -  Indication for implantation of single chamber ICD or dual chamber ICD according to
             European guidelines

        Exclusion Criteria:

          -  Age &lt; 18 and &gt; 80 years

          -  Expected non-compliance

          -  Known drug or alcohol abuse

          -  Life expectancy &lt; 1 year

          -  NYHA classification IV

          -  Participation in another clinical study

          -  Participation in another telemonitoring concept

          -  Pregnant or breast-feeding woman

          -  Uncontrolled hypertension

          -  No mobile phone use possible in patient residence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Zabel, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Faculty, University of Göttingen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Bremerhaven</name>
      <address>
        <city>Bremerhaven</city>
        <state>Niedersachsen</state>
        <zip>27574</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MH-Hannover</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiological Practice</name>
      <address>
        <city>Bonn</city>
        <state>Nordrhein-Westfalen</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincenz Hospital Paderborn</name>
      <address>
        <city>Paderborn</city>
        <state>Nordrhein-Westfalen</state>
        <zip>33098</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Bad Berka</name>
      <address>
        <city>Bad Berka</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Coburg</name>
      <address>
        <city>Coburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Hospital Barmbeck in Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>22291</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Centre Bodensee Konstanz</name>
      <address>
        <city>Konstanz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Münster</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academic Teaching Hospital Villingen of the University of Freiburg</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2008</study_first_submitted>
  <study_first_submitted_qc>November 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2008</study_first_posted>
  <last_update_submitted>June 25, 2012</last_update_submitted>
  <last_update_submitted_qc>June 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>F. Mueller-Riemenschneider</investigator_full_name>
    <investigator_title>PD, Dr.</investigator_title>
  </responsible_party>
  <keyword>Patients with ventricular arrhythmias and the prevention of sudden cardiac death</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

